Combined drugs cooperatively decreased the proliferation rate of all the ALK positive ALCL cell lines tested, with an effect defined as synergistic to strongly synergistic, depending on the ALK inhibitor and the cell line. This evidence concerns the gene ALK and anaplastic large cell lymphoma.